Advertisement

Recalcitrant Asthma

  • Sharmilee M. Nyenhuis
  • William W. Busse
Part of the Allergy Frontiers book series (ALLERGY, volume 5)

Asthma is increasing in both prevalence and severity throughout the world [1]. Asthma affects approximately 8% of the adult population and up to 20% of the pediatric population in North America, Europe, and Australia [2]. The majority of these patients have mild to moderate persistent asthma that can be well controlled by environmental control measures and appropriate use of controller and reliever medications. It is estimated, however, that 5–10% of patients with asthma have severe disease that is recalcitrant to typical treatment modalities, including, in some cases, the administration of systemic corticosteroids. These patients have the greatest impairment in lifestyles, highest morbidity, and a disproportionate amount of health care cost associated with this disease [3–5]. Women and minorities share these burdens disproportionately as well. Our understanding of the pathophysiology of this subset of asthma patients is poorly understood. Consequently, these patients need a careful evaluation to uncover risk factors and novel approaches to control the disease.

Keywords

Obstructive Sleep Apnea Severe Asthma Allergy Clin Immunol Respir Crit Peak Expiratory Flow 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wenzel SE, Szefler SJ, Leung DYM, Sloan SI, Rex MD, Martin RJ (1997) Bronchoscopic Evaluation of Severe Asthma. Am J Respir Crit Care Med 156:737–743PubMedGoogle Scholar
  2. 2.
    Burney P (1993) Epidemiology of asthma. Allergy 48:17–21CrossRefPubMedGoogle Scholar
  3. 3.
    Serra-Batlles J, Plaza V, Morejon E, Comella A, Brugues J (1998) Costs of asthma according to the degree of severity. Eur Resp J 12:1322–1326CrossRefGoogle Scholar
  4. 4.
    Antonicelli L, Bucca C, Neri M, De Benedetto F, Sabbatani P, Bonifazi F, Eichler H-g, Zhang Q, Yin DD (2004) Asthma severity and medical resource utilisation. Eur Resp J 23:723–729CrossRefGoogle Scholar
  5. 5.
    Godard P, Chanez P, Siraudin L, Nicoloyannis N, Duru G (2002) Costs of asthma are correlated with severity: A 1-yr prospective study. Eur Resp J 19:61–67CrossRefGoogle Scholar
  6. 6.
    Rackemann FM (1927) Studies in asthma: A clinical survey of 1,074 patients with asthma followed for two years. J Lab Clin Med 12:1185–1197Google Scholar
  7. 7.
    Walker IC (1918) A clinical study of 400 patients with bronchial asthma. Boston Med Surg J 179:288–293Google Scholar
  8. 8.
    Busse WW, Banks-Schlegel S, Wenzel SE (2000) Pathophysiology of severe asthma. J Allergy Clin Immunol 106:1033–1042CrossRefPubMedGoogle Scholar
  9. 9.
    American Thoracic Society (2000) Proceeding of the ATS workshop on Refractory Asthma: Current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 162:2341–2351Google Scholar
  10. 10.
    Wenzel S (2005) Severe Asthma in Adults. Am J Respir Crit Care Med 172:149–160CrossRefPubMedGoogle Scholar
  11. 11.
    Wenzel SE, Busse WW (2007) Severe asthma: Lessons from the Severe Asthma Research Program (SARP). J Allergy Clin Immunol 119:14–21CrossRefPubMedGoogle Scholar
  12. 12.
    Chanez P, Wenzel SE, Anderson G, Anto JM, Bel EH, Boulet L-P, Brightling CE, Busse WW, Castro M, Dahlen B, Dahlen SE, Fabbri LM, Holgate ST, Humbert M, Gaga M, Joos GF, Levy B, Rabe KF, Sterk PJ, Wilson SJ, Vachier I (2007) Severe Asthma: What are the important questions? J Allergy Clin Immunol 119:1337–1348CrossRefPubMedGoogle Scholar
  13. 13.
    ENFUMOSA study group (2003) The ENFUMOSA cross-sectional European multi-center study of the clinical phenotype of chronic severe asthma. Eur Respir J 22:470–477CrossRefGoogle Scholar
  14. 14.
    Turner-Warwick M (1977) On observing patterns of airflow obstruction in chronic asthma. Br J Dis Chest 71:73–86CrossRefPubMedGoogle Scholar
  15. 15.
    Ayres JG, Miles JF, Barnes PJ (1998) Brittle Asthma. Thorax 53:315–321CrossRefPubMedGoogle Scholar
  16. 16.
    Barnes PJ (1992) Poorly perceived asthma. Thorax 47:408–409CrossRefPubMedGoogle Scholar
  17. 17.
    Town GI, Allan C (1989) Ventilatory responses to hypoxia and hypercapnea in asthmatics with previous respiratory failure. Aust NZ J Med 19:426–30Google Scholar
  18. 18.
    Phelan PD, Robertson CF, Olinsky A (2002) The Melbourne Asthma Study: 1964–1999. J Allergy Clin Immunol 109:189–194CrossRefPubMedGoogle Scholar
  19. 19.
    Reed CE (2006) The natural history of asthma. J Allergy Clin Immunol 188:543–548CrossRefGoogle Scholar
  20. 20.
    Sunyer J, Soriano J, Anto JM, Burgos F, Pereira A, Payo F, Martinez-Moratalla J, Ramos J (2000) Sensitization to individual allergens as risk factors for lower FEV1 in young adults. European Community Respiratory Health Survey. Int J Epidemiol 29:499–503CrossRefGoogle Scholar
  21. 21.
    Mascia K, Haselkorn T, Deniz YM, Miller DP, Bleecker ER, Borish L (2005) Aspirin sensitivity and severity of asthma: Evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol 116:970–975CrossRefPubMedGoogle Scholar
  22. 22.
    Dompleling E, van Schayck CP, van Grunsven PM, van Herwaardën CL, Akkermans R, Molema J, Folgering H, van Weel C (1993) Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids: A 4-year prospective study. Ann Intern Med 188:770–778Google Scholar
  23. 23.
    Taussig LM, Wright AL, Holberg CJ, Halonen M, Morgan WJ, Martinez FD (2003) Tuscon Children's Respiratory Study: 1980 to present. J Allergy Clin Immunol 111:661–675CrossRefPubMedGoogle Scholar
  24. 24.
    Sanford AJ, Chagani T, Zhu S, Weir TD, Bai TR, Spinelli JJ, Fitzgerald JM, Behbehani NA, Tan WC, Paré PD (2000) Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severity. J Allergy Clin Immunol 106:135–140CrossRefGoogle Scholar
  25. 25.
    Burchard EG, Silvermann EK, Rosenwasser LJ, Borish L, Yandava C, Pillari A, Weiss ST, Hasday J, Lilly CM, Ford JG, Drazen JM (1999) Association between a sequence variant in the IL-4 gene promoter and FEV1 in asthma. Am J Respir Crit Care Med 160:919–922PubMedGoogle Scholar
  26. 26.
    Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, Klinnert M, Borish L (1995) Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 25:74–78CrossRefPubMedGoogle Scholar
  27. 27.
    Deichmann KA, Heinzmann A, Forster J, Dischinger S, Mehl C. Bruggenolte E, Hildebrandt F, Moseler M, Kuehr J (1998) Linkage and allelic association of atopy and markers flanking the IL4-receptor gene. Clin Exp Allergy 28:151–155CrossRefPubMedGoogle Scholar
  28. 28.
    Rosa-Rosa L, Zimmermann N, Bernstein JA, Rothenberg ME, Khurana-Hershey GK (1999) The R576 IL-4 receptor a allele correlated with asthma severity. J Allergy Clin Immunol 104:1008–1014CrossRefPubMedGoogle Scholar
  29. 29.
    Van Eerdewegh P, Little RD, Dupuis J, Del Mastro RG, Falls K, Simon J, Torrey D, Pandit S, McKenny J, Braunschweiger K, Walsh A, Liu Z, Hayward B, Folz C, Manning SP, Bawa A, Saracino L, Thackston M, Benchekroun Y, Capparell N, Wang M, Adair R, Feng Y, Dubois J, FitzGerald MG, Huang H, Gibson R, Allen KM, Pedan A, Danzig MR, Umland SP, Egan RW, Cuss FM, Rorke S, Clough JB, Holloway JW, Holgate ST, Keith TP (2002) Association of the ADAM-33 gene with asthma and bronchial hyper-responsiveness. Nature 418:426–430CrossRefPubMedGoogle Scholar
  30. 30.
    Holgate ST, Davies DE, Powell RM, Holloway JW (2005) ADAM33: A newly identified gene in the pathogenesis of asthma. Immunol Allergy Clin North Am 25:655–669CrossRefPubMedGoogle Scholar
  31. 31.
    Haitchi HM, Powell RM, Shaw TJ, Howarth PH, Wilson SJ, Wilson DI, Holgate ST, Davies DE (2005) ADAM33 expression in asthmatic airways and human embryonic lungs. Am J Respir Crit Care Med 171:958–965CrossRefPubMedGoogle Scholar
  32. 32.
    Jongepier H, Boezen HM, Dijkstra A, Howards TD, Vonk JM, Koppelman GH, Zheng SL, Meyers DA, Bleecker ER, Postma DS (2004) Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma. Clin Exp Allergy 34:757–760CrossRefPubMedGoogle Scholar
  33. 33.
    Lee JY, Park SW, Chang HK, Kim HY, Rhim T, Lee JH, Jang AS, Koh ES, Park CS (2006) A disintegrin and Metalloproteinase 33 protein in patients with asthma: Relevance to airflow limitation. Am J Respir Crit Care Med 173:729–735CrossRefPubMedGoogle Scholar
  34. 34.
    Contopoulos-Ioannidis DG, Manoli EN, Ioannidis JPA (2005) Meta-analysis of the association of b 2-adrenergic receptor polymorphisms with asthma phenotypes. J Allergy Clin Immunol 115:963–972CrossRefPubMedGoogle Scholar
  35. 35.
    Dolan CM, Fraher KE, Bleecker ER, Borish L, Chipps B, Hayden ML, Weiss S, Zheng B, Johnson C, Wenzel S; TENOR Study Group (2004) Design and baseline characteristics of The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study: A large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol 92:32–39PubMedGoogle Scholar
  36. 36.
    Boggess KA, Williamson HO, Homm RJ (1990) Influence of the menstrual cycle on systemic disease. Obstet Gynecol Clin North Am 17:321–342PubMedGoogle Scholar
  37. 37.
    Rosenstreich DL, Eggleston P, Katan M, Baker D, Slavin RG, Gergen P, Mitchell H, McNiff-Mortimer K, Lynn H, Ownby D, Malveaux F (1997) The Role of Cockroach Allergy and Exposure to Cockroach Allergen in Causing Morbidity Among Inner-City Children with Asthma. N Engl J Med 33:1356–1363CrossRefGoogle Scholar
  38. 38.
    ten Brinke A, Grootendorst DC, Schmidt JT, Bruïne Ft, van Buchem MA, Sterk PJ, Rabe KF, Bel EH (2002) Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol 109:621–626CrossRefPubMedGoogle Scholar
  39. 39.
    Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, Calhoun WJ, Castro M, Chung KF, Clark MP, Dweik RA, Fitzpatrick AM, Gaston B, Hew M, Hussain I, Jarjour NN, Israek E, Levy BD, Murphy JR, Peters SP, Teague WG, Meyers DA, Busse WW, Wenzel SE; National Heart, Lung, Blood Institute's Severe Asthma Research Program (2007) Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program (SARP). J Allergy Clin Immunol 119:405–413CrossRefPubMedGoogle Scholar
  40. 40.
    Bresciani M, Paradis L, Des RA, Vernhet H, Vacheir I, Godard P, Bousquet J, Chanez P (2001) Rhinosinusitis in severe asthma. J Allergy Clin Immunol 107:73–80CrossRefPubMedGoogle Scholar
  41. 41.
    Stirling RG, Chung KF (2001) Severe Asthma: Definition and mechanisms. Allergy 56:825–840CrossRefPubMedGoogle Scholar
  42. 42.
    Kraft M, Cassell GH, Henson JE, Watson H, Williamson J, Marmion BP, Gaydos CA, Martin RJ (1998) Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med 158:998–1001PubMedGoogle Scholar
  43. 43.
    ten Brinke A, van Dissel JT, Sterk PJ, Zwinderman AH, Rabe KF, Bel EH (2001) Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J Allergy Clin Immunol 107:449–454CrossRefPubMedGoogle Scholar
  44. 44.
    Holgate ST, Polosa R (2006) The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 368:780–793CrossRefPubMedGoogle Scholar
  45. 45.
    Folkerts G, Busse WW, Nijkamp FP, Sorkness R, Gern JE (1998) Virus-induced Airway hyperresponsiveness and Asthma. Am J Respir Crit Care Med 157:1708–1720PubMedGoogle Scholar
  46. 46.
    Nicholson KG, Kent J, Ireland DC (1993) Respiratory viruses and exacerbation of asthma in adults. BMJ 307:982–986CrossRefPubMedGoogle Scholar
  47. 47.
    Grunberg K, Sterk PJ (1999) Rhinivirus infections: Induction and modulation of airways inflammation in asthma. Clin Exp Allergy 29(S2):65–73PubMedGoogle Scholar
  48. 48.
    Smart JM, Horak E, Kemp AS, Robertson CF, Tand ML (2002) Polyclonal and allergen-induced cytokine responses in adults with asthma: Resolution of asthma is associated with normalization of IFN-gamma responses. J Allergy Clin Immunol 110:450–456CrossRefPubMedGoogle Scholar
  49. 49.
    Brooks GD, Buchta KA, Swanson CA, Gern JE, Busse WW (2003) Rhinovirus-induced Interferon- g and Airway Responsivenss in Asthma. Am J Respir Crit Care Med 168:1091–1094CrossRefPubMedGoogle Scholar
  50. 50.
    Tomlinson JEM, McMahon AD, Chaudhuri R, Thompmson JM, Wood SF, Thomson NC (2005) Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 60:282–287CrossRefPubMedGoogle Scholar
  51. 51.
    Chaudhuri R, Livingston E, McMahon AD, Thomson L, Borland W, Thomson NC (2003) Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 168:1308–1311CrossRefPubMedGoogle Scholar
  52. 52.
    Ito K, Lim J, Caramori G, Chung K, Barnes P, Adcock IM (2001) Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 15:1110–1112PubMedGoogle Scholar
  53. 53.
    Hakala K, Steniums-Aarniala B, Sovijarvi A (2000) Effects of weight loss on peak flow variability, airways obstruction, and lung volumes in obese patients with asthma. Chest 188:1315–1321CrossRefGoogle Scholar
  54. 54.
    Aaron SD, Fergusson D, Dent R, Chen Y, Vandemheen KL, Dales RE (2004) Effect of weight reduction on respiratory functions and airway reactivity in obese women. Chest 125:2046–2052CrossRefPubMedGoogle Scholar
  55. 55.
    Harding SM (1999) Gastroesophageal reflux and asthma: Insight into the association. J Allergy Clin Immunol 104:251–259.CrossRefPubMedGoogle Scholar
  56. 56.
    Chung KF, Godard P (1999) Difficult/therapy-resistant asthma. Eur Respir J 19:1198–1208Google Scholar
  57. 57.
    Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C (1996) Non-compliance and treatment failure in children with asthma. J Allergy Clin Immunol 98:1051–1057CrossRefPubMedGoogle Scholar
  58. 58.
    Strunk RC, Mrazek DA, Fuhrmann GS, LaBrecque JF (1985) Physiologic and psychological characteristics associated with deaths due to asthma in childhood: A case-controlled study. JAMA 254:1193–1198CrossRefPubMedGoogle Scholar
  59. 59.
    ten Brinke A, Ouwekerk ME, Bel EH, Spinhoven P (2001) Similar psychological characteristics in mild and severe asthma. J Psychosom Res 50:7–10CrossRefPubMedGoogle Scholar
  60. 60.
    ten Brinke A, Ouwekerk ME, Zwinderman AH, Spinhoven P, Bel EH (2001) Psychopathlogy in patients with severe asthma is associated with increased health care utilization. Am J Respir Crit Care Med 163:1093–1096PubMedGoogle Scholar
  61. 61.
    Kolbe J, Fergusson W, Vamos M, Garrett J (2002) Case-control study of severe life threatening asthma (SLTA) in adults: Psychological factors. Thorax 57:317–322CrossRefPubMedGoogle Scholar
  62. 62.
    Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, Chu HW (1999) Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med. 160:1001–1008PubMedGoogle Scholar
  63. 63.
    Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ (1999) Neutrophilic Inflammation in Severe Persistent Asthma. Am J Respir Crit Care Med 160:1532–1539PubMedGoogle Scholar
  64. 64.
    Wenzel, S and Szefler SS (2006) Managing severe asthma. J Allergy Clin Immunol 117:508–511CrossRefPubMedGoogle Scholar
  65. 65.
    ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH (2004) “Refractory” Eosinophilic Airway Inflammation in Severe Asthma. Am J Respir Crit Care Med 170:601–605CrossRefPubMedGoogle Scholar
  66. 66.
    Global Initiative for Asthma. Global strategy for asthma management and prevention. A six part management program. NIH publication number 02-3659 http://www.ginathma.org
  67. 67.
    Davies H, Olson L, Gibson P (2000) Methotrexate as a steroid sparing agent for asthma in adults. Cochrane Database Sys Rev 2:CD000391Google Scholar
  68. 68.
    Haque S, Boyce N, Thien FC, O'Hehir RE, Douglas J (2003) Role of intravenous immuno-globulin in severe steroid-dependent asthma. Intern Med J 33:341–344CrossRefPubMedGoogle Scholar
  69. 69.
    Salmun LM, Barlan I, Wolf HM, Eibl M, Twarog FJ, Geha RS, Schneider LC (1999) Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: A double-blind, placebo-controlled, randomized trial. J Allergy Clin Immunol 103:810–815CrossRefPubMedGoogle Scholar
  70. 70.
    Niebauer K, Dewilde S, Fox-Rushby J, Revicki DA (2006) Impact of omalizumab on quality-of-life outcomes in patients with moderate-to-severe allergic asthma. Ann Allergy Asthma Immunol 96:316–326PubMedCrossRefGoogle Scholar
  71. 71.
    O'Byrne PM (2006) Cytokines or Their Antagonists for the Treatment of Asthma. Chest 130:244–250CrossRefPubMedGoogle Scholar
  72. 72.
    Kips JC, O'Connor BJ, Langley SJ, Woodcock A, Kerstjens HAM (2003) Effect of SCH55700, a humanized anti-human IL-5 antibody, in severe persistent asthma. Am J Respir Crit Care Med 167:1655–1659CrossRefPubMedGoogle Scholar
  73. 73.
    Howarth PH, Babu KS, Arshad HS, Lau L, Buckley M, McConnell W, Beckett P, Al Ali M, Chauhan A, Wilson SJ, Reynolds A, Davies DE, Holgate ST (2005) Tumour necrosis factor (TNF a) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 60:1012–1018CrossRefPubMedGoogle Scholar
  74. 74.
    Erin EM, Leaker BR, Nicholson GC, Tan AJ, Green LM, Neighbour H, Zacharasiewisz AS, Turner J, Barnathan ES, Kon OM, Barnes PJ, Hansel TT (2006) The effects of a monoclonal antibody directed against tumor necrosis factor- a in asthma. Am J Respir Crit Care Med 174:753–762CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • Sharmilee M. Nyenhuis
    • 1
  • William W. Busse
    • 1
    • 2
  1. 1.Division of Allergy and Immunology, Department of MedicineUniversity of WisconsinMadisonUSA
  2. 2.University of Wisconsin School of Medicine and Public HealthMadisonUSA

Personalised recommendations